MLchartDataset catalogue

Aranesp

Term · Oncology and biomedicine · MLC-T-ONC-000701

A drug used to treat anemia caused by chronic kidney disease and some types of chemotherapy. Aranesp is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Aranesp is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called darbepoetin alfa.

Table 1. Record
IdentifierMLC-T-ONC-000701
FieldOncology and biomedicine
Synonymsdarbepoetin alfa
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000701",
  "term": "Aranesp",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat anemia caused by chronic kidney disease and some types of chemotherapy. Aranesp is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Aranesp is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called darbepoetin alfa.",
  "synonyms": [
    "darbepoetin alfa"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/aranesp/"
}

Record 2,409 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.